Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
AstraZeneca
Baxter
Colorcon
Express Scripts

Last Updated: January 29, 2020

DrugPatentWatch Database Preview

Xiromed Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for XIROMED, and what generic and branded alternatives to XIROMED drugs are available?

XIROMED has nineteen approved drugs.



Summary for Xiromed
US Patents:0
Tradenames:18
Ingredients:9
NDAs:19

Drugs and US Patents for Xiromed

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xiromed NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone acetate TABLET, CHEWABLE;ORAL 209609-001 Jul 16, 2018 AB RX No No   Start Trial   Start Trial
Xiromed VIENVA ethinyl estradiol; levonorgestrel TABLET;ORAL-28 201088-001 May 21, 2015 AB1 RX No No   Start Trial   Start Trial
Xiromed ALTAVERA ethinyl estradiol; levonorgestrel TABLET;ORAL-28 079102-001 Aug 3, 2010 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
AstraZeneca
McKinsey
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.